Skip to main content
Premium Trial:

Request an Annual Quote

Sanford-Burnham Taps Genedata Screener for Chemical Genomics

Premium

Genedata said this week that Sanford-Burnham's chemical genomics arm has selected its Screener software to parse libraries containing chemical compounds and natural products as part of its drug discovery pipeline.

Specifically, researchers at two sites that are part of the Conrad Prebys Center for Chemical Genomics are using the platform to process high-content and high-throughput screening data.

They will use the system to determine the best datasets for hit selection as well as identify hits that "may otherwise be lost," Christian Hassig, director of drug discovery at the center, said in a statement.

According to Susanne Heynen-Genel, who directs the HCS core facility at the center, Genedata Screener "eliminates tedious manual handling of single plates and the lag time traditionally experienced when accessing different systems and files."

For researchers involved in HTS data processing at Sanford-Burnham, Screener replaces plate-by-plate analysis, which is time-consuming and error-prone, Ying Su, director of cheminformatics and HTS Informatics at the chemical genomics center, said in a statement.

Financial details about the Sanford-Burnham licensing agreement were not disclosed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.